Literature DB >> 26152660

The role of viral co-infection in HIV-associated non-AIDS-related cancers.

David J Riedel1, Lydia S Tang, Anne F Rositch.   

Abstract

HIV-infected individuals are at increased risk for most types of cancer, including those typically classified as non-AIDS-defining cancers (NADCs). This increased risk is likely multifactorial, but a prominent risk factor for the increased rate of some cancers is co-infection with oncogenic viruses. Anal cancer, hepatocellular carcinoma, and Hodgkin lymphoma are three of the most common NADCs, and they are associated with co-infection with human papillomavirus, hepatitis B and C, and Epstein Barr virus, respectively. This review will examine the epidemiology, pathogenesis, and future trends around these virally associated NADCs frequently found in HIV-infected individuals.

Entities:  

Mesh:

Year:  2015        PMID: 26152660      PMCID: PMC4890557          DOI: 10.1007/s11904-015-0276-6

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  101 in total

1.  Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States.

Authors:  L Conley; T Bush; T M Darragh; J M Palefsky; E R Unger; P Patel; E M Kojic; S Cu-Uvin; H Martin; E T Overton; J Hammer; K Henry; C Vellozzi; K Wood; J T Brooks
Journal:  J Infect Dis       Date:  2010-10-06       Impact factor: 5.226

2.  Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals.

Authors:  Daniel Grint; Lars Peters; Juergen K Rockstroh; Aza Rakmanova; Tatiana Trofimova; Karine Lacombe; Igor Karpov; Massimo Galli; Pere Domingo; Ole Kirk; Jens D Lundgren; Amanda Mocroft
Journal:  AIDS       Date:  2015-06-19       Impact factor: 4.177

3.  High cancer-related mortality in an urban, predominantly African-American, HIV-infected population.

Authors:  David J Riedel; Evelyn Ivy W Mwangi; Lori E Fantry; Carla Alexander; Mian B Hossain; C David Pauza; Robert R Redfield; Bruce L Gilliam
Journal:  AIDS       Date:  2013-04-24       Impact factor: 4.177

4.  Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study.

Authors:  Jianhua Yin; Nan Li; Yifang Han; Jie Xue; Yang Deng; Jie Shi; Weixing Guo; Hongwei Zhang; Hongyang Wang; Shuqun Cheng; Guangwen Cao
Journal:  J Clin Oncol       Date:  2013-09-03       Impact factor: 44.544

5.  Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus.

Authors:  Yasushi Shiratori; Shuichiro Shiina; Takuma Teratani; Masatoshi Imamura; Shun'taro Obi; Shin'pei Sato; Yukihiro Koike; Haruhiko Yoshida; Masao Omata
Journal:  Ann Intern Med       Date:  2003-02-18       Impact factor: 25.391

Review 6.  Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions.

Authors:  Brooke E Hoots; Joel M Palefsky; Jeanne M Pimenta; Jennifer S Smith
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

7.  Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.

Authors:  Thomas P Giordano; Louise Henderson; Ola Landgren; Elizabeth Y Chiao; Jennifer R Kramer; Hashem El-Serag; Eric A Engels
Journal:  JAMA       Date:  2007-05-09       Impact factor: 56.272

8.  High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.

Authors:  Christophe Piketty; Teresa M Darragh; Isabelle Heard; Maria Da Costa; Patrick Bruneval; Michel D Kazatchkine; Joel M Palefsky
Journal:  Sex Transm Dis       Date:  2004-02       Impact factor: 2.830

9.  Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

Authors:  Adriaan J van der Meer; Bart J Veldt; Jordan J Feld; Heiner Wedemeyer; Jean-François Dufour; Frank Lammert; Andres Duarte-Rojo; E Jenny Heathcote; Michael P Manns; Lorenz Kuske; Stefan Zeuzem; W Peter Hofmann; Robert J de Knegt; Bettina E Hansen; Harry L A Janssen
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

Review 10.  HIV-associated Hodgkin lymphoma.

Authors:  Antonino Carbone; Annunziata Gloghini; Diego Serraino; Michele Spina
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

View more
  7 in total

1.  Virologic and Immunologic Outcomes in HIV-Infected Patients with Cancer.

Authors:  David J Riedel; Kristen A Stafford; Aparna Vadlamani; Robert R Redfield
Journal:  AIDS Res Hum Retroviruses       Date:  2016-12-13       Impact factor: 2.205

2.  Epidemiological risk factors associated with primary infection by Epstein-Barr virus in HIV-1-positive subjects in the Brazilian Amazon region.

Authors:  Leonn Mendes Soares Pereira; Eliane Dos Santos França; Iran Barros Costa; Igor Tenório Lima; Amaury Bentes Cunha Freire; Francisco Lúzio de Paula Ramos; Talita Antonia Furtado Monteiro; Olinda Macedo; Rita Catarina Medeiros Sousa; Felipe Bonfim Freitas; Igor Brasil Costa; Antonio Carlos Rosário Vallinoto
Journal:  Sci Rep       Date:  2021-09-16       Impact factor: 4.996

3.  Cancer Incidence and Cancer Screening Practices Among a Cohort of Persons Receiving HIV Care in Washington, DC.

Authors:  Amanda Blair Spence; Matthew E Levy; Anne Monroe; Amanda Castel; Joseph Timpone; Michael Horberg; Lucile Adams-Campbell; Princy Kumar
Journal:  J Community Health       Date:  2021-02

Review 4.  A Review of Management of Inflammation in the HIV Population.

Authors:  Jihad Slim; Christopher F Saling
Journal:  Biomed Res Int       Date:  2016-09-27       Impact factor: 3.411

5.  Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.

Authors:  Oumar Billa; Mathieu Chalouni; Dominique Salmon; Isabelle Poizot-Martin; Camille Gilbert; Christine Katlama; Didier Neau; Julie Chas; Philippe Morlat; Karine Lacombe; Alissa Naqvi; Karl Barange; Anne Gervais; Olivier Bouchaud; Eric Rosenthal; Caroline Lascoux-Combe; Daniel Garipuy; Laurent Alric; Stéphanie Dominguez; Daniel Vittecoq; Cécile Goujard; Claudine Duvivier; Hugues Aumaitre; Patrick Miailhes; David Zucman; Anne Simon; Estibaliz Lazaro; François Raffi; Laure Esterle; Linda Wittkop; Firouzé Bani-Sadr
Journal:  PLoS One       Date:  2018-12-18       Impact factor: 3.240

6.  Epstein-Barr Virus (EBV) Genotypes Associated with the Immunopathological Profile of People Living with HIV-1: Immunological Aspects of Primary EBV Infection.

Authors:  Leonn Mendes Soares Pereira; Eliane Dos Santos França; Iran Barros Costa; Igor Tenório Lima; Amaury Bentes Cunha Freire; Francisco Lúzio de Paula Ramos; Talita Antonia Furtado Monteiro; Olinda Macedo; Rita Catarina Medeiros Sousa; Felipe Bonfim Freitas; Igor Brasil Costa; Antonio Carlos Rosário Vallinoto
Journal:  Viruses       Date:  2022-01-18       Impact factor: 5.048

7.  Cancer risk following lymphoid malignancies among HIV-infected people.

Authors:  Parag Mahale; Chinenye Ugoji; Eric A Engels; Meredith S Shiels; Sally Peprah; Lindsay M Morton
Journal:  AIDS       Date:  2020-07-01       Impact factor: 4.632

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.